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Abstract 
Telomeres are higher order structures that cap and protect chromosome ends. 
Telomeric DNA naturally shortens during somatic cell division and as a result of 
oxidative stress. Excessive shortening disrupts the integrity of the telomere, causing 
cellular senescence, one of the hallmarks of organismal ageing. The accumulation of 
senescent cells with ageing contributes to the loss of tissue homeostasis and the 
development of age-related pathologies. Hence, counteracting telomere shortening 
may be one relevant approach to develop strategies for healthier ageing. In this 
review I present the case for the existence of a link between oxidative stress, 
accelerated telomere shortening and cellular senescence. I also examine findings 
from human observational studies exploring associations between telomere length 
and oxidative stress-related parameters. Finally, I discuss results from randomised 
control trials testing the impact of non-pharmacological lifestyle interventions on the 
maintenance of telomere length, considering the potential mechanisms that might be 
involved. 
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Introduction 
Telomeres are higher-order structures made of a tandemly repeated guanine-rich 
DNA sequence (TTAGGG in vertebrates) and a specialized protein complex called 
shelterin, that cap and stabilize the physical ends of chromosomes, protecting them 
from degradation and end-to-end fusions [1, 2]. Synthesis and maintenance of 
telomeric DNA requires in addition to DNA polymerase, a specialized reverse 
transcriptase called telomerase [3, 4]. In humans telomerase is tightly regulated by 
differentiation and proliferation signals. It is expressed at high levels in embryonic 
tissues and adult stem cell compartments, but is hardly detectable, in most other 
human adult somatic cell types [5, 6]. In addition, telomerase activity may be 
upregulated in some cells under stimulatory conditions, e.g. in endothelial cells by 
growth factors [6, 7] or in lymphocytes by activation signals [8]. 
Due to the inability of conventional DNA polymerases to replicate the 5’-end of the 
lagging strand, when telomerase is repressed DNA synthesis during cell division 
results in a gradual loss of telomeric DNA [9]. In addition, because of its high 
guanine content, telomeric DNA is intrinsically susceptible to oxidative modifications 
and single strand break formation [10]. Furthermore, since at the telomere oxidative 
lesions are less efficiently removed, at the time of replication persistent lesions may 
also lead to the truncation of the telomeric DNA backbone (reviewed in [11]). 
Accordingly, work with cultured cells has shown that oxidative stress accelerates 
telomere shortening [12, 13]. 
Erosion of telomeric DNA eventually compromises the functional integrity of the 
whole telomere structure, triggering a DNA damage response, which in turn may 
result in the onset of cellular senescence [14]. Cellular senescence is a distinctive 
stress-response phenomenon that enforces an essentially irreversible cell-cycle 
arrest. In addition, it gives rise to a secretory phenotype endowed with pro-
inflammatory, growth promoting and tissue remodelling properties [15]. This 
response may be beneficial in early life and adulthood, for example as an anti-
neoplastic mechanism [16], or to promote wound healing [17]. In contrast, in later 
life, due to the age-related impairment of clearance systems, an accumulation of 
senescent cells equipped with a pro-inflammatory baggage is thought to contribute to 
the loss of tissue homeostasis and the development of age-related pathologies 
(reviewed in [18]. 
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In human cells telomeric DNA is heterogeneous in length, measuring between ~4 to 
~15 kb. A decrease in leukocyte telomere length (LTL), which generally correlates 
with telomere length in other body tissues [19, 20], is a feature of normal ageing [21]. 
In addition, greater telomere shortening in leukocytes or peripheral blood 
mononuclear cells (PBMC) is associated with an increased risk of age-related 
diseases [4, 22, 23] and mortality [4, 24, 25]. Hence, counteracting telomere 
shortening may be relevant to reduce the accumulation of senescent cells and their 
pathological consequences. 
Telomere length is influenced by biological [26-29], environmental [30], psychosocial 
[31-35] and life-style factors [36-40]. These include, gene variants of telomerase and 
telomere protective proteins, epigenetic signatures, sex, paternal age at birth, 
ethnicity, body size, biological stress responsivity, levels of inflammation, tobacco 
smoking, physical activity, diet and nutrition, as well as psychosocial stress, 
education and pollution levels. Some of these factors are also known to affect the 
oxidative burden of the organism, raising the possibility that they influence telomere 
shortening in this way. In this review I summarize evidence linking oxidative stress to 
telomere shortening in vivo and highlight areas of controversy. Furthermore, given 
that the harmful biological impacts of some of the above factors could be mitigated 
by changing life style behaviours, I also discuss non-drug interventions that may 
have the potential to reduce telomere shortening via oxidative stress-suppressing 
mechanisms. 
The relationships between oxidative stress and telomere length in humans 
Heightened levels of reactive oxygen species (ROS) can cause macromolecular 
damage and thus contribute to the development of ageing phenotypes [41-43]. This 
notion, together with early research in cultured cells showing that biological 
mediators of disease which induce oxidative stress, also shorten telomeres and lead 
to premature senescence (reviewed in [7]), prompted a search for associations in 
vivo between telomere length and markers of oxidative damage or antioxidant 
defences. One of the first indications that linked oxidative stress with shorter 
telomeres in humans came from a small study investigating the relationship of these 
parameters with perceived psychological stress in healthy pre-menopausal women 
[31]. An inverse correlation between LTL and urine levels of the isoprostane 8-epi-
PGF2α, a marker of lipid peroxidation, was subsequently described in a larger sample 
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of Caucasian men [44]. However, further studies carried out in different population 
settings revealed a mixed picture (Table 1). Thus, associations between telomere 
length and selected markers of oxidative damage or antioxidant defences were 
found in type II diabetes or Parkinson’s disease but not in healthy individuals [45-47]. 
Associations with plasma antioxidant micronutrients [48] and with oxidative stress-
related gene polymorphisms [49] have also been documented. On the other hand, a 
handful of studies reported no associations. Thus, research investigating risks for 
breast cancer found no significant correlations between telomere length and urinary 
levels of 8-hydroxy-2-deoxyguanosine (8-OHdG) or 15-F2-isoprostanes, either in the 
patient group or in the healthy controls [50]. Similarly, no correlations between LTL 
and diverse oxidative stress-related blood markers were found in Spanish patients 
with cardiovascular disease [51] or in mostly healthy Chinese individuals [52], except 
for a positive association with superoxide dismutase in the latter. 
Importantly, in a recent study which examined interactions between redox state 
markers and telomere length in blood versus vascular tissue of patients with 
coronary artery disease, tissue-specific inverse associations between superoxide 
production and telomere length were described [53]. Furthermore, these 
relationships were influenced by the additive effects of two functional single 
nucleotide polymorphisms in the CYBA gene, which encodes one of the NADPH 
oxidase subunits, thus, suggesting causality. In addition, the study showed no 
associations between telomere length of blood cells and either plasma superoxide 
dismutase activity or total plasma anti-oxidant capacity, or between vascular 
telomere length and vascular superoxide dismutase activity, suggesting that 
antioxidant defences played no role in the regulation of telomere length. 
Thus, taken together the available evidence only lends partial support to the concept 
that oxidative stress contributes to telomere shortening in vivo. Several factors could 
contribute to the discrepancies found between studies, including the ethnical and 
clinical characteristics of the populations studied, the type of tissue sampled and the 
markers of oxidative stress tested. Of note however, in those studies that reported 
associations with telomere length, only a minority showed these to be with 
antioxidant defences. 
Non-pharmacological interventions 
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A substantial number of observational studies have described associations between 
telomere length and potentially modifiable lifestyle behaviours, although conflicting 
results have also been reported (reviewed in [54-60]). These observations led the 
way for interventional studies aimed at ascertaining whether non-pharmacological 
approaches focusing on life-style changes could influence telomere length. The first 
clear indication that such interventions might have an effect came from a five-year 
follow-up study carried out in men at low risk of prostate cancer [61]. At the end of 
the study the group that engaged in a comprehensive life-style change programme, 
which included diet, physical activity, stress management and social support, 
showed a significant increase in PBMC telomere length compared to a decrease in 
the control group [61]. Using a randomised control trial (RCT) design, other studies 
have evaluated mainly four distinct intervention modalities, namely diet composition, 
physical activity, weight loss and psychological stress management. Table 2 
summarizes examples of such RCTs lasting for at least eight weeks. The studies 
were generally small and heterogeneous with respect to the age and health 
characteristics of the participants, as well as the duration of the interventions. The 
majority lasted for less than a year [62-72], while four trials were conducted for a 
year or more [73-77]. In all of them telomere length was determined in either 
leukocytes or PBMC before and after the intervention. However, although the type of 
interventions described are known to impinge on oxidative-stress responses [78-82], 
only a few related telomere length measurements to changes in oxidative stress-
related parameters [62, 64, 65]. A brief description of these studies is summarized 
below. 
Dietary interventions 
Some of the health benefits of fish-rich diets have been attributed to a high content 
of long chain omega-3 (n-3) polyunsaturated fatty acids (PUFAs) and the capacity of 
these compounds to decrease oxidative stress [83, 84]. In this respect, small trials 
have attempted to ascertain whether n-3 PUFA supplementation also affected 
telomere length. In one trial where participants received two different doses of n-3 
PUFAs or a placebo for four months, changes in plasma F2-isoprostanes were also 
recorded. In this study increases in telomere length in the PUFA supplementation 
groups were observed, compared to a decrease in the placebo group, although the 
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differences between groups were not significant [62]. However, a secondary analysis 
revealed that the increases in telomere length were associated with decreasing 
plasma n-6:n-3 PUFA ratios. n-3 PUFA supplementation was also shown to 
significantly reduce F2-isoprostanes, but an attempt to correlate this measure with 
telomere length was apparently not carried out in this case [62]. A second trial with 
participants suffering from mild cognitive impairment evaluated a six month 
intervention with supplements rich in the n-3 PUFAs eicosapentanoic acid (EPA) or 
docosahexanoic acid (DHA) against the n-6 PUFA linolenic acid (LA) as the control 
[63]. In this case, telomere length decreased more in the LA group than in the DHA 
or EPA groups, but the differences were not statistically significant. Nevertheless, it 
was found that in the DHA group an increase in red blood cell DHA levels correlated 
with reduced telomere shortening [63]. Thus, while the above two studies do not 
seem to have sufficient statistical power to reach to a firm conclusion, taken together 
they suggest that telomere shortening may be attenuated by n-3 PUFA 
supplementation. Consistent with these findings, in an opportunistic two year trial 
conducted in cognitively healthy elders, a diet rich in walnuts, which is a source of n-
3 PUFAs, showed a trend to preserve telomere length when compared to a control 
diet [73]. 
The Mediterranean diet (MD) is rich in sources of bioactive compounds that are 
thought to play a role in protecting the organism against inflammation and other 
sources of oxidative stress [60]. This protective function may be achieved in part by 
activating detoxifying stress responses, which in vitro are known to ameliorate 
telomere shortening and senescence [85]. In vivo, the effect of the MD on telomere 
length has been examined in a relatively large RCT, which had been originally 
designed to investigate the effects of this diet on the primary prevention of 
cardiovascular disease. In this study participants who were given the MD 
supplemented with olive oil showed no differences in telomere erosion over a five 
year period when compared to a control group given a low fat diet; unexpectedly, 
accelerated telomere shortening was observed in participants on the MD 
supplemented with nuts [75]. Importantly however, the study found that greater 
adherence to the MD reduced telomere shortening in individuals carrying the Ala 
variant of the PPARγ2 gene, but not in those carrying the Pro variant [74]. Thus, 
although the study concluded that overall there was no beneficial effect of the MD 
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intervention on slowing telomere shortening in comparison to a low fat diet, it also 
highlighted the potential relevance of genetic factors when considering the effects of 
diets on telomere length. Unfortunately, although the MD is known to increase 
antioxidant defences [86] and reduce oxidative damage [87] in this high 
cardiovascular risk population, no comparisons between changes in oxidative stress 
markers and changes in telomere length were reported in this case. 
Exercise and physical activity 
Physical exercise increases ROS generation acutely. This in turn triggers an anti-
oxidant defence response, which with regular exercise practice becomes protective 
[88]. This protection against oxidative stress is one mechanism by which physical 
activity might reduce telomere attrition. To test this concept, the effect of exercise 
training or increase in physical activity on telomere length was investigated in small 
RCTs carried out in a variety of settings (Table 2). Some of the studies also 
examined the effect of the intervention on enzymes involved in redox homeostasis 
[64, 65] or on telomerase activity [67, 89]. One intervention carried out in obese 
middle age women showed that although six month of aerobic exercise training 
resulted in an increase in glutathione peroxidase activity, it did not cause significant 
changes in telomere length [64]. In another study which evaluated the effect of a 
twelve week low frequency explosive-type resistance training in elderly people, 
telomere length increased in the intervention group and decreased in the control 
group, the difference in telomere length between trained and untrained participants 
being significant [65]. In this study, significant reductions of mitochondrial superoxide 
dismutase 2 and thioredoxin reductase 1 in PBMC, as well as in serum 
myeloperoxidase, were detected in the intervention group but not in controls [65]. In 
a third study in which overweight older adults received physical activity of 
low/moderate intensity on prescription for six months there were no significant 
differences in telomere length between the control and the intervention group. 
However, in the exercise group a reduction in the sitting time was strongly correlated 
with telomere lengthening, whereas no such correlation was observed in the control 
group [66]. More recently, in one RCT conducted with family caregivers, aerobic 
exercise training was shown to increase telomere length after six months, without 
causing changes in telomerase activity [67]. In contrast, in another RCT carried out 
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with healthy sedentary postmenopausal women, twelve month of aerobic exercise 
showed no effect on telomere length [76]. Finally, a recent RCT in healthy sedentary 
participants compared the effects of three exercise training modalities on telomerase 
activity and telomere length in PBMCs [89]. Notably, this study found that aerobic 
endurance training or high intensity interval training for six month increased both 
telomerase activity and telomere length; in contrast, no such changes were induced 
by resistance training. Thus, this study suggest that in otherwise sedentary healthy 
people, specific training protocols may have differential effects on telomere length. 
Weight loss 
Calorie restriction causing weight loss without malnutrition has been shown to 
improve telomere length maintenance [90, 91] as well as to reduce oxidative stress 
and senescence [90] in lean mice. Conversely, mice made obese by feeding a high 
fat diet show increased levels of oxidative DNA damage and a reduction in telomere 
length, compared to lean animals fed a normal chow [92]. In agreement with findings 
in mice, obesity is one of the factors more consistently associated with telomere 
shortness in human observational studies [29, 56]. However, whether low calorie 
diets aimed at reducing weight, ameliorate telomere attrition also in humans, remains 
to be demonstrated. Indeed, in a RCT that examined the effects of calorie restriction 
on predictors of longevity and disease risk factors in healthy non-obese individuals, 
telomere length was not measured [93]. Furthermore, in obese or overweight 
participants, low calorie diets on their own or in combination with physical activity 
have not reduced telomere shortening significantly [69, 77]. Thus, in a relatively large 
study in older women carried out over a twelve-month period, there were no 
significant changes in LTL in any intervention group, whether weight loss had been 
achieved by dietary restriction, aerobic exercise or a combination of both, compared 
to controls. In this study, no association between the magnitude of weight loss and 
telomere length was found either [77]. Similarly, in another smaller trial carried out in 
breast cancer survivors, which combined exercise with diet, while an increase in 
telomere length was detected in the intervention group at six months compared to a 
decrease in the control group, the difference between groups was not significant 
[69]. 
Stress management 
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A variety of studies has reported associations between telomere length, telomerase 
activity and psychosocial stress (reviewed in [94]) but the mechanisms underlying 
these relationships remain to be fully elucidated. Chronic psychological stress has 
been linked to higher levels of oxidative DNA damage and decrease in anti-oxidant 
defences [54], possibly triggered in part by higher levels of the stress-related 
hormone cortisol [95]. In support of this possibility, a longitudinal study in healthy late 
middle age people has recently suggested that heightened cortisol responsivity may 
mediate the relationship between psychological stress and telomere shortening [28]. 
It should be noted however, that the effect of cortisol on telomere length could be 
mediated also by an inhibition of telomerase activity [96] and not necessarily only by 
oxidative stress. In addition, other pathways could be involved in this relationship, 
including a psychological stress-induced increase in pro-inflammatory cytokines [97, 
98], which are also known be associated to greater telomere attrition [62]. 
Attenuating the physiological components of the stress response is a reasonable 
strategy to reduce the effects of psychological stress on telomere length and cellular 
ageing. In this context, a growing interest in the relationship between telomere length 
and psychological stress management has emerged over the last few years [99]. 
Yoga and meditation are two modalities that might reduce levels of systemic 
inflammation, stress-hormones and oxidative stress. These practices have also been 
linked with increases in telomerase activity and/or the amelioration of telomere 
maintenance in some observational and interventional studies [82, 99]. Two studies 
in particular examined the effect of yoga on telomere-related parameters and redox 
markers [100, 101]. The first one was a case-control study, which found that 
experienced yoga practitioners had significantly longer leukocyte telomeres, a higher 
total anti-oxidant status, and lower levels of malondialdehyde and homocysteine in 
serum, compared to healthy controls. In addition, in this study a strong correlation 
between telomere length and each of the redox markers was reported, suggesting 
that habitual yoga practice ameliorates telomere shortening by reducing systemic 
oxidative stress levels [100]. The second study was a prospective single arm 
exploratory trial lasting for three months in which 94 healthy participants were 
subjected to a yoga and meditation-based lifestyle intervention [101]. In this study, 
levels of 8-OHdG and ROS were significantly lower after the intervention compared 
to baseline, while the total anti-oxidant capacity and telomerase activity were 
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significantly higher. In contrast, although telomere length was shown to increase, the 
difference was not significant [101]. Notably, and consistent with this finding a 
handful of small RCTs lasting between two and nine months has shown no effect of 
meditation practices on telomere length (Table 2). Taken together, these studies 
suggest that stress management techniques on their own are unlikely to 
demonstrate significant effects on telomere length if applied for relatively short 
periods of time (e.g. for less than two years). 
Conclusions, challenges and future perspectives 
Mounting evidence indicates that life-style changes aimed at promoting health and 
wellbeing do so by reducing the pro-inflammatory and oxidative burden of the 
organism. In line with this notion, as described in this review, over the last 10 years 
an increasing number of RCT have tested whether non-drug interventions known for 
their oxidative stress-reducing potential, could also help to maintain telomere length 
over time. However, although mechanistically plausible, the picture that emerges 
from those studies is at present equivocal (Figure 1). Aside from limitations in the 
precision and heterogeneity of methods to measure telomere length and oxidative 
stress, including in some cases, the shortcoming inherent to the use of a single 
biomarker to measure the latter, inconsistencies between findings may be due to a 
variety of additional factors. These include the demographic, genetic and health 
characteristics of the groups studied, as well as the duration and intensity of the 
interventions. Furthermore, some studies could have been statistically underpowered 
to detect significant changes in telomere length. Finally, concerning the duration of 
the interventions, it should be emphasised that the majority lasted for less than a 
year and it is unclear whether telomere length can indeed change with interventions 
of such length [102, 103]. 
In considering the biological mechanisms that are recruited by non-pharmacological 
treatments, one should contemplate the role of telomerase (Figure 1). The weight of 
evidence suggests that meditation can reactivate telomerase in leukocytes with 
relatively short interventions [99]. Similarly, mouse and human studies indicate that 
exercise can also induce an increase in telomerase activity [68, 104]. Notably, in one 
prospective human study the exercise-induced increase in telomerase activity was 
shown to precede an increase in telomere length [104]. However, telomerase activity 
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and telomere length do not show always a positive correlation [61, 99, 105]; thus, 
whether such re-activation can affect telomere shortening in different scenarios is 
unclear. Telomerase activity is under multiple controls, some of which are also 
influenced by redox mechanisms [106]. Furthermore, oxidative stress supresses 
telomerase activity in vitro [13], although it is not known whether this is relevant in 
vivo. Thus, in evaluating the link between oxidative stress and telomere length in 
vivo, cross-talk between telomerase activity and the redox status of the organism 
and/or the relevant cell type should also be considered. 
For practical reasons in human studies telomere length has been mostly measured 
in leukocytes or PBMC. In this respect, it should be considered that the expansion of 
leukocyte subsets that occurs during inflammation and immunological responses 
may also cause accelerated telomere shortening, irrespective of the levels of 
oxidative stress to which these cells are subjected. In fact, measurement of telomere 
length in blood should be regarded as a measure of the senescent status of 
circulating immune cells. Thus, to take account of these potential confounding effects 
future interventional studies should also look at tissues other than blood, for example 
the buccal epithelium. 
Taken together the current evidence suggest that longer, larger (adequately 
powered) and better-designed RCT are required in order to confirm whether lifestyle 
changes are effective in reducing telomere-related cellular senescence. Larger 
interventions would also allow for stratification according to genetic variants and thus 
establish if genetic factors modulate the effectiveness of some of these interventions. 
These studies should consider where possible, taking samples from tissues other 
than blood, and include several reliable measures of oxidative stress, which are 
relevant to the cells and tissues from which telomere length measurements are 
taken. Finally, we should not neglect the notion that social and public health 
measures, aimed at increasing the educational attainment of the population or 
reduce pollution levels, are bona fide non-pharmacological interventions with a much 
wider remit, which might also contribute to extend health span by reducing telomere-
related cellular senescence. 
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Figure Legend 
Figure 1: Targeting telomere shortening and senescence by life-style interventions 
that activate telomerase and/or reduce oxidative stress. The dashed line indicates a 
possible connection 
 
Table 1: Human observational studies exploring the association between telomere length and oxidative stress-related parameters  
Tissue 
Population 
or disease 
Sample 
size 
Age* 
Association with oxidative stress-related 
parameters ** 
Reference 
WBC vs 
urine/serum 
Healthy women 
caregivers vs controls 
19 control 
39 carers 
38  
(20-50) 
Negative w/ F2-isoprostane/VitE index 
(F(1,40)=3.49;P=0.035) 
[31] 
WBC vs urine  
Framingham Heart 
Study Caucasian men 
327 
62.2  
(40-89) 
8-epi-PGF2α (r=−0.16; P=0.005) [44] 
WBC 
Caucasian men with 
T2D vs controls 
28 control 
21 T2D 
61.5 
(50-65) 
8-oxoguanine (r=−0.55; P=0.018) in T2D only [45] 
WBC vs plasma Caucasian T2D patients 561 
68  
(24–92) 
TAC (r=0.12, P<0.01) [46] 
WBC vs plasma 
Parkinson’s disease 
(PD) vs controls 
20 PD 
15 control 
>65 
protein carbonyls (r=−0.544, P=0.04) in PD only 
NOT w/SOD or GSH in either control, PD or overall 
[47] 
WBC vs plasma 
Austrian Stroke 
Prevention Study 
786 
66 
(46-85) 
Antioxidant micronutrients: Lutein-zeaxanthin (β= 
0.120, P=0.006), Vitamin C β=0.146, P=0.004 
[48] 
WBC  
1921 Lothian Birth 
Cohort and Newcastle 
Thousand Family Study 
190 LBC 
 
318 NTF 
79 
 
50 
Oxidative stress-related gene polymorphisms 
Methionine sulfoxide reductase A and 
NADH:Ubiquinone dehydrogenase A3 in both cohorts 
[49] 
WBC vs urine 
Women from the Long 
Island Breast Cancer 
Study 
1061 cases 
1108 
controls 
(20-98) NOT w/ 15-F2 isoprostane or 8-OHdG [50] 
WBC vs plasma 
Spanish CVD patients of 
CORDIOPREV study 
290 (20-75) 
NOT with lipid peroxides, GSH,GSSG, protein 
carbonyls, nitrotyrosine, NO or GPx activity 
[51] 
WBC vs serum Chinese population 556 53.2 (11.7) 
Positive w/ serum SOD (P=0.001) 
NOT w/ glutathione reductase or 8-OHdG  
[52] 
WBC, plasma 
saphenous vein 
(SV), mammary 
artery (IMA)  
Stable CAD patients 
128 WBC 
32 IMA 
24 SV 
65.9 (9.6) 
Tissue specific with O2
· -
 production (IMA: r=−0.49, 
P=0.004; SV: r=−0.52, P=0.01). Weak w/ plasma 
MDA. NOT w/ plasma SOD or plasma TAC. Influence 
of CYBA gene (p22
phox
) polymorphisms 
[53] 
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*Age is indicated as median or mean and/or (range or SD) 
** Where data are available the strength of associations are described by correlations coefficients (r), ANCOVA F-statistics or standardized regression 
cofficients (β) 
CAD, coronary artery disease; GSH, Glutathione; GSSG, oxidized glutathione; GPx, Glutathione peroxidase; MDA: malondyaldehyde; NO, nitric oxide; SOD, 
superoxide dismutase; TAC: total antioxidant capacity; T2D, type 2 diabetes; WBC, white blood cells 
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Table 2: Randomised controlled trials of non-drug interventions to modulate telomere length 
Intervention Population Age
* 
Study Design Main findings Reference 
n-3 PUFA 
supplements 
Healthy 
overweight U.S. 
subjects 
40-85 
1.25 g/d (n=40) or 2.5 g/d (n=35) n-3 
PUFA vs placebo (n=31); 4m 
15% ↓urinary F-2 isoprostanes in PUFA groups 
↔ΔTL between groups; association between ↑TL 
and ↓plasma n-6:n-3 PUFA ratio (P=0.02) 
[62] 
n-3 PUFA 
supplements 
Australian 
subjects w/ MCI 
>65 
EPA (n=12) or DHA (n=12) vs LA 
(n=9); 6m 
↔ΔTL between groups; correlation of RBC ΔDHA 
with ΔTL in DHA group (r=-0.67, P=0.02) 
[63] 
Walnut-rich 
diet 
Cognitively 
healthy Spanish 
elders 
63-79 
Walnut rich diet (n=80) vs habitual 
diet (n=69); 2y 
↔ΔTL between groups but tendency to reduced 
attrition in walnut diet group 
[73] 
Mediterranean 
diet 
PREDIMED-
NAVARRA high 
CVD risk Spanish 
subjects  
55-80 
MD +olive oil (n=211) or MD+ nuts 
(n=170) vs control low fat diet 
(n=140); 5y 
↑ΔTL by high adherence to MD in PPARγ2 gene 
Ala carriers but not in Pro/Pro carriers (P< 0.001); 
↔ΔTL in MD + EV olive oil vs control, ↑-ΔTL in MD 
+ nuts vs control (P=0.003) 
[74, 75] 
Aerobic 
exercise 
Obese middle age 
women 
47 (6) 
supervised aerobic exercise (EX) 
(n=8) vs control (n=8); 6m 
↔TL in control or EX group; ↔serum MDA or 
SOD, ↑ GPX (P<0.05) in EX group 
[64] 
Resistance 
training 
Elderly people 70-75 
explosive moderate intensity 
resistance training (EMRT) (n=10) vs 
control (n=10); 12 w 
↑ TL in EMRT group vs control group (P<0.05); 
↓MnSOD (P<0.01), ↓TrxR1 (P<0.01), ↓MPO 
(P<0.05) in EMRT group vs baseline 
[65] 
Physical 
activity on 
prescription 
Sedentary 
overweight older 
adults 
68 
individualised low/moderate 
intensity physical activity (n=24) vs 
control (n=25), 6m  
↔TL exercise vs control; correlation of ΔTL with 
reduced sitting time in exercise group (r=−0.68, 
P=0.02) 
[66] 
Aerobic 
exercise 
Family caregivers 
with high stress 
61 (6) 
highly supervised aerobic exercise 
(n=34) vs control (n=34); 6 m 
↔TA in either group; ↔ ΔTL in control group 
↑ΔTL in exercise group (P=0.03) 
[67] 
Aerobic 
exercise 
Healthy 
postmenopausal 
sedentary women 
50-74 
highly supervised aerobic exercise 
(n=99) vs usual inactivity (113); 1y 
↔ ΔTL between groups [76] 
Various 
exercise 
modalities 
Healthy 
sedentary men 
and women 
30-60 
aerobic endurance (AET) (n=26), 
interval (IT) (n=29) or resistance 
training (RT) (n=34) vs control (n=35); 
↑ΔTA (P<0.01) and ↑ΔTL (P<0.05) in AET or IT 
↔ΔTA and ↔ΔTL in RT or controls 
[89] 
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6m 
Weight loss 
Overweight or 
obese U.S older 
women 
50-75 
dietary weight loss (n=118), aerobic 
exercise (n=117) or diet + exercise 
(n=117) vs control (n=87); 1y 
↔ΔTL in any intervention vs control; no 
association between Δ weight loss and ΔTL 
[77] 
Weight loss 
Overweight or 
obese breast 
cancer surviving 
women 
58 (8) 
diet + exercise (n=93) vs usual care 
control (n=58), 6m 
↔ΔTL between groups [69] 
Mindfulness-
based group 
therapy 
Patients with 
depression, 
anxiety or stress 
and adjustment 
disorders 
20-64 
mindfulness based group therapy 
(n=88) vs treatment as usual control 
(n=89); 8w 
↔ TL vs baseline or between groups [70] 
Mindfulness-
based group 
therapy 
Breast cancer 
survivors 
55 (9) 
8w of mindfulness-based cancer 
recovery (n=34), 12w of supportive 
expressive group therapy (n=36) vs 
control (n=18)  
↔TL vs baseline ,but trend effect between 
combined intervention groups vs control group (F 
(1,84)=3.82, P=0.054) 
[71] 
Contemplative 
mental 
training 
Healthy adults 20-55 
mental training (n=222) vs control 
(n=76); 9 m 
↔ ΔTL between groups  [72] 
 
*age is indicated as mean (SD) or range 
Abbreviations: CVD, cardiovascular disease; DHA, docosahexanoic acid; EPA, eicosapentanoic acid; LA, linolenic acid; MDA, malondyaldehyde; MCI, mild 
cognitive impairment, PUFA, polyunsaturated fatty acids; SOD, superoxide dismutase; TL, telomere length; RBC, red blood cells; 
↔, no significant difference between groups, ↑, increase; ↓, decrease  
 

Highlights 
 
• Oxidative stress accelerates telomere shortening resulting in cellular 
senescence 
• There is evidence linking oxidative stress to telomere shortening in humans 
• Non-drug interventions that curb oxidative stress may reduce telomere 
shortening 
